文献
J-GLOBAL ID:202202267699781433
整理番号:22A0449824
進行固形腫瘍患者における抗PD-1,ドスタリマブの安全性,抗腫瘍活性および薬物動態: 用量漸増第1相試験【JST・京大機械翻訳】
Safety, antitumor activity, and pharmacokinetics of dostarlimab, an anti-PD-1, in patients with advanced solid tumors: a dose-escalation phase 1 trial
著者 (14件):
Patnaik Amita
(South Texas Accelerated Research Therapeutics, San Antonio, TX, USA)
,
Weiss Glen J.
(Western Regional Medical Center, Cancer Treatment Centers of America, Goodyear, AZ, USA)
,
Weiss Glen J.
(SOTIO, LLC, Cambridge, MA, USA)
,
Rasco Drew W.
(South Texas Accelerated Research Therapeutics, San Antonio, TX, USA)
,
Blaydorn Lisa
(Western Regional Medical Center, Cancer Treatment Centers of America, Goodyear, AZ, USA)
,
Mirabella Amy
(HonorHealth Research Institute/Translational Genomics Research Institute (TGen), Scottsdale, AZ, USA)
,
Beeram Murali
(South Texas Accelerated Research Therapeutics, San Antonio, TX, USA)
,
Guo Wei
(GlaxoSmithKline, Waltham, MA, USA)
,
Lu Sharon
(GlaxoSmithKline, Waltham, MA, USA)
,
Danaee Hadi
(GlaxoSmithKline, Waltham, MA, USA)
,
Danaee Hadi
(Blueprint Medicines, Cambridge, MA, USA)
,
McEachern Kristen
(Ribon Therapeutics, Cambridge, MA, USA)
,
Im Ellie
(GlaxoSmithKline, Waltham, MA, USA)
,
Sachdev Jasgit C.
(HonorHealth Research Institute/Translational Genomics Research Institute (TGen), Scottsdale, AZ, USA)
資料名:
Cancer Chemotherapy and Pharmacology
(Cancer Chemotherapy and Pharmacology)
巻:
89
号:
1
ページ:
93-103
発行年:
2022年
JST資料番号:
W4134A
ISSN:
1432-0843
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
ドイツ (DEU)
言語:
英語 (EN)